Icon plc Stock
€274.70
Your prediction
Icon plc Stock
Pros and Cons of Icon plc in the next few years
Pros
Cons
Performance of Icon plc vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Icon plc | 0.220% | -5.743% | -10.454% | 40.026% | 6.035% | - | - |
Alkermes plc | -2.630% | -5.932% | -11.905% | -17.164% | -11.200% | 35.366% | -25.000% |
Ironwood Pharmaceuticals | -0.670% | -1.342% | -6.369% | -28.641% | -29.327% | -17.416% | -36.856% |
Novocure Ltd | -1.720% | -14.085% | -11.150% | -80.505% | -20.736% | -92.957% | - |
Comments
News
ICON Announces CFO Transition
ICON plc (NASDAQ: ICLR), a world-leading healthcare intelligence and clinical research organization, today announced that Chief Financial Officer, Brendan Brennan, will leave his role at ICON in
ICON plc Schedules First Quarter 2024 Earnings Conference Call
ICON plc (NASDAQ: ICLR), a world-leading healthcare intelligence and clinical research organization, today announced that it will release its financial results for the first quarter 2024 after the
ICON plc to Present at Upcoming Investor Conferences
ICON plc, (NASDAQ: ICLR) a world-leading clinical research organization powered by healthcare intelligence, today announced that Mr. Brendan Brennan, CFO of ICON plc, will present at the TD Cowen